Panacos Pharmaceuticals

(OTC) PANC

Current Price$0.00

Market Cap$100

Since IPO (2005)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Panacos Pharmaceuticals Financials at a Glance

Market Cap

$100

Revenue (TTM)

$99.00K

Net Income (TTM)

$35.76M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

142.68 (High)

Dividend

$0.00

Beta (Volatility)

142.68 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Dividend

$0.00

Beta (Volatility)

142.68 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

PANC News

So-So Results From Panacos

Brian LawlerDec 13, 2007

Making Cents in Penny Stocks

Rich DupreyNov 26, 2007

Get Ready for the Bounce

Rich SmithJul 2, 2007

Panacos Validates Itself

Brian LawlerJun 21, 2007

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Panacos Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Headquarters

Watertown, 02472, US

PANC Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

217%

Net Income Margin

-208%

Return on Equity

Return on Capital

85%

Return on Assets

-67%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

53.64M

Volume

Avg. Volume

1.905

Financials (TTM)

Gross Profit

$180.00K

Operating Income

$39.02M

EBITDA

$38.23M

Operating Cash Flow

$31.04M

Capital Expenditure

$48.00K

Free Cash Flow

$31.08M

Cash & ST Invst.

$51.90M

Total Debt

$19.31M

Panacos Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2008YOY CHG

Revenue

$24.00K

-20.0%

Gross Profit

$24.00K

-20.0%

Gross Margin

100.00%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$2.44

N/A

Employees

N/A

Net Income

$8.15M

-3.0%

EBITDA

$7.26M

+10.3%

Quarterly Fundamentals

Name

Q3 2008YOY CHG

Net Cash

$8.68M

-77.9%

Accounts Receivable

$101.00K

-24.6%

Inventory

$0.00

N/A

Long Term Debt

$11.15M

+27.2%

Short Term Debt

$7.05M

+12275.4%

Return on Assets

-67.24%

N/A

Return on Invested Capital

84.82%

N/A

Free Cash Flow

$7.80M

-12.2%

Operating Cash Flow

$7.80M

-12.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CALACalithera Biosciences, Inc.

CALACalithera Biosciences, Inc.$0.00+0.00%

TLOGTetraLogic Pharmaceuticals Corporation

TLOGTetraLogic Pharmaceuticals Corporation$0.00+0.00%

KLDOKaleido Biosciences, Inc.

KLDOKaleido Biosciences, Inc.$0.00+0.00%

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

IVBTInnovation1 Biotech Inc.

IVBTInnovation1 Biotech Inc.$0.00+0.00%

IYXIInyx, Inc.

IYXIInyx, Inc.$0.00+0.00%

BTTXBetter Therapeutics, Inc.

BTTXBetter Therapeutics, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.14-0.01%

INTCIntel

INTCIntel$95.78-0.04%

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$7.84+2.39%

GBTGGlobal Business Travel Group

GBTGGlobal Business Travel Group$9.34+0.58%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.18+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.69-0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.20-0.01%

Questions About PANC

What is the current price of Panacos Pharmaceuticals?

Panacos Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Panacos Pharmaceuticals?

Over the past 52 weeks, Panacos Pharmaceuticals has traded between N/A and N/A.

How much debt does Panacos Pharmaceuticals have?

Panacos Pharmaceuticals total debt is unavailable.

How much cash does Panacos Pharmaceuticals have on hand?

Panacos Pharmaceuticals does not have cash on hand data available.

What is Panacos Pharmaceuticals’s dividend yield?

Panacos Pharmaceuticals does not currently have a dividend yield.

Panacos Pharmaceuticals

Panacos Pharmaceuticals Financials at a Glance

PANC News

So-So Results From Panacos

Making Cents in Penny Stocks

Better Late Than Never for Panacos

Stop Dragging, Panacos

The CEO Who Battles HIV

Panacos' Plans

Get Ready for the Bounce

Panacos Validates Itself

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Panacos Pharmaceuticals

PANC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Panacos Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PANC

What is the current price of Panacos Pharmaceuticals?

What is the 52-week range for Panacos Pharmaceuticals?

How much debt does Panacos Pharmaceuticals have?

How much cash does Panacos Pharmaceuticals have on hand?

What is Panacos Pharmaceuticals’s dividend yield?

Premium Investing Services